According to Liu et al., this elevated expression is stimulated by tumor-repopulating cells (TRCs) in CD8+ T cells through a transcellular pathway involving kynurenine (Kyn) and the aryl hydrocarbon receptor (AhR) [47]. The gene discussed is CD8A; the disease is neoplasm.